COMP <GO>
UHS vs JNJ // FREE CASH FLOW YIELD
Universal Health Services Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: UHS 7
— JNJ 8
▲ FREE CASH FLOW YIELD LEADER: UHS
LAST: $176.05 (-0.32%) • MKT CAP: $10.41B
fcf-yield
8.16%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
fcf-yield
2.97%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UHS VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UHS | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.10% | 25.50% | -11.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.0x | 18.5x | -13.50 | UHS | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 8.16% | 2.97% | +5.19 | UHS | /fcf-yield <GO> |
| Operating Margin | 11.50% | 34.70% | -23.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 28.50% | -19.90 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 6.00% | +3.70 | UHS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 0.00% | +0.49 | UHS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.11 | 5.59 | -2.48 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | UHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 7.20% | -0.20 | UHS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 60.4 | -14.69 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 1.08 | -0.04 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.5x | 23.0x | -16.50 | UHS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.41B | $662.49B | -$652.08B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UHS REV | JNJ REV | UHS GROSS % | JNJ GROSS % | UHS FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.36B | $94.19B | 44.0% | 67.9% | $849.2M | $19.70B |
| FY 2024 | $15.83B | $88.82B | 44.0% | 69.1% | $1.12B | $19.84B |
| FY 2023 | $14.28B | $85.16B | 44.0% | 44.0% | $625.1M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UHS // BETA 1.04
JNJ // BETA 1.08